---
name: Medicap Laboratories
slug: medicaplab
site: cdmo
website_domain: medicaplab.com
summary: Canadian CDMO for advanced oral drug delivery, offering contract manufacturing, pharmaceutical packaging, analytical testing and product development. Proprietary Hypermatrix, PODRAS and nPODDDS platforms target controlled-release and abuse-deterrent products. Headquartered in Etobicoke, Canada.
tagline: Canadian CDMO for advanced oral drug delivery
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CA
tier2_domain_verified: false
updated_at: 2026-11-02T07:02:57.152Z
services_count: 5
modalities_count: 1
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Medicap Laboratories

Canadian CDMO for advanced oral drug delivery

Listed on cdmo.directory.

## Summary

Canadian CDMO for advanced oral drug delivery, offering contract manufacturing, pharmaceutical packaging, analytical testing and product development. Proprietary Hypermatrix, PODRAS and nPODDDS platforms target controlled-release and abuse-deterrent products. Headquartered in Etobicoke, Canada.

## At a glance

- HQ country: CA

## Services

- Formulation Development
- Process Development
- Oral Solid Dosage Manufacturing
- Secondary Packaging & Labeling
- Quality Control Testing

## Modalities

- Small Molecule

## Locations

- Etobicoke, Etobicoke, Ontario, Canada

## Long description

Medicap Laboratories describes itself as a Canadian contract development and manufacturing organization (CDMO) with a global outlook, focused on advanced oral drug delivery.

## Services

- **Contract Manufacturing**
- **Pharmaceutical Packaging**
- **Analytical Testing**
- **Product Development**

The company describes a full-service CDMO model that runs from R&D through commercial manufacturing, packaging and testing. It states that its regulatory, formulation and scale-up expertise supports generic, complex and specialty formulations.

## Patented technologies

The company lists several proprietary platforms:

- **Hypermatrix**
- **PODRAS**
- **nPODDDS**
- Abuse Deterrent Technology
- Other controlled-release (CR) platforms

According to the site, these are intended for optimized drug release, enhanced bioavailability and lifecycle management, with applications in controlled-release, biphasic and abuse-deterrent products.

## Engagement model

The site says business development staff can work from a defined RFP or from early-stage ideas. It also states a focus on transparent communication, proactive problem solving and quality and timelines across the product lifecycle.

## Location

The contact page lists an address at 30 Worcester Rd, Etobicoke, ON, Canada.

## Related companies

- [Codis](/companies/codis) (Formulation Development, Process Development) — [Compare](/compare/codis/medicaplab)
- [Confab](/companies/confab) (Formulation Development, Process Development) — [Compare](/compare/confab/medicaplab)
- [Glatt](/companies/glatt) (Formulation Development, Process Development) — [Compare](/compare/glatt/medicaplab)
- [Bend Bioscience](/companies/bend-bioscience) (Formulation Development, Process Development) — [Compare](/compare/bend-bioscience/medicaplab)
- [UPM Pharmaceuticals](/companies/upm-inc) (Formulation Development, Process Development) — [Compare](/compare/medicaplab/upm-inc)
- [Amneal Pharmaceuticals](/companies/amneal-pharmaceutical) (Formulation Development, Process Development) — [Compare](/compare/amneal-pharmaceutical/medicaplab)
- [ReAgent Chemical Services](/companies/reagent-co) (Formulation Development, Process Development) — [Compare](/compare/medicaplab/reagent-co)
- [Halo Pharma](/companies/halo-pharma) (Formulation Development, Process Development) — [Compare](/compare/halo-pharma/medicaplab)

_Profile last updated: 2026-11-02T07:02:57.152Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.